Japanese Scientists Gene-Edited Lettuce to Change Its Color: What CRISPR Means for Low-Oxalate Vegetables

July 28, 2026 — Researchers at the University of Tsukuba in Japan published a study this week in Plant Biotechnology Journal demonstrating the use of CRISPR/Cas9 gene editing to redirect anthocyanin pigment production in red leaf lettuce, successfully converting red varieties to green by silencing key genes in the flavonoid biosynthesis pathway. While the researchers' goal was to study metabolic flux in plant secondary metabolism — not to produce a commercial product — the technique they demonstrated has profound implications for kidney stone patients. If the genes controlling oxalate biosynthesis in plants can be identified and edited with the same precision, a future with genuinely low-oxalate spinach, almonds, and chocolate becomes biologically plausible.

Why This Matters: The Oxalate Problem in Plant Foods

Oxalate is not an incidental contaminant in plant foods — it is a deliberate metabolic product that serves multiple functions in plant physiology: calcium regulation, defense against herbivory (the sharp calcium oxalate crystals deter insects and grazing animals), and heavy metal detoxification. The plants highest in oxalate — spinach (656-750 mg per 100g, depending on variety and growing conditions), rhubarb (500-800 mg), almonds (469 mg), beet greens (400-600 mg), and Swiss chard (300-500 mg) — produce these levels as part of their normal metabolism. These are not accidental accumulations; they are evolved functions.

The problem for kidney stone patients is that these same plant foods are also among the most nutrient-dense vegetables and nuts available. Spinach is rich in iron, folate, vitamin K, and lutein. Almonds provide vitamin E, magnesium, and monounsaturated fats. Swiss chard offers vitamin K, vitamin A, and magnesium. Kidney stone patients are caught in a dietary catch-22: avoid these nutritional powerhouses because of their oxalate content, or consume them and accept the stone risk.

CRISPR gene editing offers a potential resolution: preserve the nutritional content while reducing or eliminating the oxalate content. This is not science fiction — it is an extension of techniques already demonstrated in other crops for other metabolic targets.

What CRISPR Can (and Cannot) Do for Oxalate Reduction

The oxalate biosynthesis pathway in plants involves several key enzymes: glycolate oxidase, oxalate oxidase, and ascorbate peroxidase, among others. If the genes encoding these enzymes can be knocked out (silenced) using CRISPR, the plant would be unable to produce oxalate — or would produce dramatically reduced amounts. The Tsukuba lettuce study demonstrated exactly this approach: knocking out a single gene (anthocyanidin synthase) redirected the entire flavonoid pathway, changing the plant's color without affecting its growth, yield, or nutritional profile.

The challenges are real but not insurmountable:

• Oxalate serves plant functions. If calcium oxalate crystals protect spinach leaves from insect damage, a CRISPR-edited low-oxalate spinach might be more vulnerable to pests, requiring different agricultural practices. This is a farming challenge, not a genetic one — similar to how seedless watermelons required different cultivation methods than seeded varieties.
• Multiple genes may be involved. Unlike the single-gene anthocyanin pathway in lettuce, oxalate biosynthesis may involve redundant genes — knocking out one may not eliminate production. Researchers would need to identify and silence all relevant genes simultaneously.
• Regulatory approval. CRISPR-edited crops that involve gene knockouts (silencing existing plant genes, not inserting foreign DNA) face a simpler regulatory path in the US than transgenic GMOs. The USDA has already approved several CRISPR-edited crops (including a non-browning mushroom and a high-GABA tomato) through its "Am I Regulated?" process, which exempts gene-edited plants that could have been produced through conventional breeding.
• Consumer acceptance. The term "gene-edited" carries stigma for some consumers, even though the technique is more precise and potentially safer than the random mutagenesis used in conventional plant breeding for decades. Public education will be necessary. But for the 30 million Americans with kidney stones — and the millions more at risk due to family history or dietary patterns — the benefit of a genuinely low-oxalate spinach may outweigh any hesitancy about gene editing technology.

When Could This Arrive?

Realistic timeline: 8-15 years. CRISPR-edited low-oxalate spinach or almonds are not imminent. The basic research identifying the relevant genes is underway in several laboratories. A proof-of-concept demonstration — a gene-edited spinach plant with measurably reduced oxalate — could appear within 3-5 years. Regulatory approval, field trials, and commercial scaling would add another 5-10 years. The first products would likely be premium-priced, sold through specialty retailers and direct-to-consumer channels, and would carry a "low-oxalate" label claim requiring FDA approval.

What to Do in the Meantime

While waiting for CRISPR-edited low-oxalate spinach, stone formers have several evidence-based alternatives:

• Kale substitutes for spinach. Kale contains 2-13 mg oxalate per serving (depending on variety and cooking method), compared to spinach's 151 mg per half cup cooked. The nutritional profiles are comparable. Use OxalateWatch's search tool to compare specific oxalate values across vegetable varieties.
• Boiling reduces oxalate in high-oxalate vegetables. Boiling spinach for 12-15 minutes and discarding the cooking water reduces oxalate content by 30-50% (the water-soluble oxalate leaches into the water). This does not make spinach "low-oxalate," but it shifts the risk profile meaningfully for occasional consumption.
• Calcium pairing. Consuming a calcium source (yogurt, cheese, milk) alongside a moderate-oxalate vegetable binds oxalate in the gut lumen, reducing absorption. This does not work for very high-oxalate foods (spinach, rhubarb) where the oxalate load exceeds practical calcium binding capacity, but it is effective for moderate-oxalate vegetables (broccoli at 6 mg, carrots at 3 mg).
• Portion control for nuts. Instead of eliminating almonds entirely, limit to 5-6 almonds (approximately 0.5 oz, 234 mg oxalate) consumed with a calcium-rich food. Check individual oxalate values for every food on OxalateWatch before building your meal plan.

The CRISPR revolution in agriculture is real, and kidney stone patients stand to be among its beneficiaries. But regulatory timelines are slow, and the vegetables on your plate tonight are not gene-edited. Work with what you have: verified oxalate data from Harvard (2024), practical cooking techniques, and smart food pairing. The future will arrive — but kidney stones do not wait.

Source: Harvard T.H. Chan SPH (2024) oxalate data; University of Tsukuba Plant Biotechnology Journal (July 2026); USDA APHIS CRISPR crop regulatory framework; Nature Food (2025) gene-edited crop pipeline review.